請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/40672完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 阮雪芬 | |
| dc.contributor.author | Kai-Lin Cheng | en |
| dc.contributor.author | 程凱麟 | zh_TW |
| dc.date.accessioned | 2021-06-14T16:55:25Z | - |
| dc.date.available | 2013-08-05 | |
| dc.date.copyright | 2008-08-05 | |
| dc.date.issued | 2008 | |
| dc.date.submitted | 2008-07-29 | |
| dc.identifier.citation | Adomas, A., G. Heller, et al. (2008). Comparative analysis of transcript abundance in Pinus sylvestris after challenge with a saprotrophic, pathogenic or mutualistic fungus. Tree Physiol 28, 885-97.
Akahoshi, E., S. Yoshimura, et al. (2006). Over-expression of AhR (aryl hydrocarbon receptor) induces neural differentiation of Neuro2a cells: neurotoxicology study. Environ Health 5, 24. Bader, G. D. and C. W. Hogue (2002). Analyzing yeast protein-protein interaction data obtained from different sources. Nat Biotechnol 20, 991-7. Bammler, T., R. P. Beyer, et al. (2005). Standardizing global gene expression analysis between laboratories and across platforms. Nat Methods 2, 351-6. Brodeur, G. M., F. A. Hayes, et al. (1987). Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients. Cancer Res 47, 4248-53. Brodeur, G. M., J. M. Maris, et al. (1997). Biology and genetics of human neuroblastomas. J Pediatr Hematol Oncol 19, 93-101. Brodeur, G. M., J. Pritchard, et al. (1993). Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11, 1466-77. Brodeur, G. M., R. C. Seeger, et al. (1988). International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol 6, 1874-81. Castleberry, R. P. (1997). Neuroblastoma. Eur J Cancer 33, 1430-7; discussion 1437-8. Churchill, G. A. (2002). Fundamentals of experimental design for cDNA microarrays. Nat Genet 32 Suppl, 490-5. Cotterill, S. J., A. D. Pearson, et al. (2000). Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group 'Survey' 1982-1992. Eur J Cancer 36, 901-8. Evans, A. E., G. J. D'Angio, et al. (1971). A proposed staging for children with neuroblastoma. Children's cancer study group A. Cancer 27, 374-8. Fong, C. T., N. C. Dracopoli, et al. (1989). Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification. Proc Natl Acad Sci U S A 86, 3753-7. Gavin, A. C., M. Bosche, et al. (2002). Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature 415, 141-7. Grady-Leopardi, E. F., M. Schwab, et al. (1986). Detection of N-myc oncogene expression in human neuroblastoma by in situ hybridization and blot analysis: relationship to clinical outcome. Cancer Res 46, 3196-9. Grovas, A., A. Fremgen, et al. (1997). The National Cancer Data Base report on patterns of childhood cancers in the United States. Cancer 80, 2321-32. Guengerich, F. P. (1992). Metabolic activation of carcinogens. Pharmacol Ther 54, 17-61. Hayes, F. A., A. Green, et al. (1983). Surgicopathologic staging of neuroblastoma: prognostic significance of regional lymph node metastases. J Pediatr 102, 59-62. Hoehner, J. C., C. Gestblom, et al. (1996). A developmental model of neuroblastoma: differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage. Lab Invest 75, 659-75. Hsu, W. M., Y. M. Jen, et al. (2006). The influence of biologic factors on the surgical decision in advanced neuroblastoma. Ann Surg Oncol 13, 238-44. Ito, T., T. Chiba, et al. (2001). A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc Natl Acad Sci U S A 98, 4569-74. Jayapandian, M., A. Chapman, et al. (2007). Michigan Molecular Interactions (MiMI): putting the jigsaw puzzle together. Nucleic Acids Res 35, D566-71. Jin, D. Q., J. W. Jung, et al. (2004). 2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibits cell proliferation through arylhydrocarbon receptor-mediated G1 arrest in SK-N-SH human neuronal cells. Neurosci Lett 363, 69-72. Kramps, C., V. Strieder, et al. (2004). E2F and Sp1/Sp3 Synergize but are not sufficient to activate the MYCN gene in neuroblastomas. J Biol Chem 279, 5110-7. Kwak, M. K. and T. W. Kensler (2006). Induction of 26S proteasome subunit PSMB5 by the bifunctional inducer 3-methylcholanthrene through the Nrf2-ARE, but not the AhR/Arnt-XRE, pathway. Biochem Biophys Res Commun 345, 1350-7. Lausted, C., T. Dahl, et al. (2004). POSaM: a fast, flexible, open-source, inkjet oligonucleotide synthesizer and microarrayer. Genome Biol 5, R58. Lonergan, G. J., C. M. Schwab, et al. (2002). Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation. Radiographics 22, 911-34. Maris, J. M. and K. K. Matthay (1999). Molecular biology of neuroblastoma. J Clin Oncol 17, 2264-79. Marlowe, J. L. and A. Puga (2005). Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis. J Cell Biochem 96, 1174-84. Maslov, S. and K. Sneppen (2002). Specificity and stability in topology of protein networks. Science 296, 910-3. Matthay, K. K., H. N. Sather, et al. (1989). Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy. J Clin Oncol 7, 236-44. Nevins, J. R. (1992). E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258, 424-9. Nguyen, T. A., D. Hoivik, et al. (1999). Interactions of nuclear receptor coactivator/corepressor proteins with the aryl hydrocarbon receptor complex. Arch Biochem Biophys 367, 250-7. Okey, A. B., G. P. Bondy, et al. (1980). Temperature-dependent cytosol-to-nucleus translocation of the Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in continuous cell culture lines. J Biol Chem 255, 11415-22. Oliver, T. G., L. L. Grasfeder, et al. (2003). Transcriptional profiling of the Sonic hedgehog response: a critical role for N-myc in proliferation of neuronal precursors. Proc Natl Acad Sci U S A 100, 7331-6. Perdew, G. H. (1988). Association of the Ah receptor with the 90-kDa heat shock protein. J Biol Chem 263, 13802-5. Perdew, G. H. (1992). Chemical cross-linking of the cytosolic and nuclear forms of the Ah receptor in hepatoma cell line 1c1c7. Biochem Biophys Res Commun 182, 55-62. Poellinger, L. (2000). Mechanistic aspects--the dioxin (aryl hydrocarbon) receptor. Food Addit Contam 17, 261-6. Pollenz, R. S., C. A. Sattler, et al. (1994). The aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein show distinct subcellular localizations in Hepa 1c1c7 cells by immunofluorescence microscopy. Mol Pharmacol 45, 428-38. Pritchard, J. and J. A. Hickman (1994). Why does stage 4s neuroblastoma regress spontaneously? Lancet 344, 869-70. Puga, A., C. R. Tomlinson, et al. (2005). Ah receptor signals cross-talk with multiple developmental pathways. Biochem Pharmacol 69, 199-207. Riley, D. J., E. Y. Lee, et al. (1994). The retinoblastoma protein: more than a tumor suppressor. Annu Rev Cell Biol 10, 1-29. Sartelet, H., L. Grossi, et al. (2002). Detection of N-myc amplification by FISH in immature areas of fixed neuroblastomas: more efficient than Southern blot/PCR. J Pathol 198, 83-91. Schena, M., D. Shalon, et al. (1995). Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270, 467-70. Schwab, M., H. E. Varmus, et al. (1985). Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture. Nature 316, 160-2. Seeger, R. C., G. M. Brodeur, et al. (1985). Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313, 1111-6. Shannon, P., A. Markiel, et al. (2003). Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13, 2498-504. Strieder, V. and W. Lutz (2003). E2F proteins regulate MYCN expression in neuroblastomas. J Biol Chem 278, 2983-9. Suzuki, M., S. Okuyama, et al. (1998). A novel E2F binding protein with Myc-type HLH motif stimulates E2F-dependent transcription by forming a heterodimer. Oncogene 17, 853-65. Tang, T., N. Francois, et al. (2007). Expression ratio evaluation in two-colour microarray experiments is significantly improved by correcting image misalignment. Bioinformatics 23, 2686-91. Weiss, W. A., K. Aldape, et al. (1997). Targeted expression of MYCN causes neuroblastoma in transgenic mice. Embo J 16, 2985-95. White, P. S., J. M. Maris, et al. (1995). A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc Natl Acad Sci U S A 92, 5520-4. Whitlock, J. P., Jr. (1999). Induction of cytochrome P4501A1. Annu Rev Pharmacol Toxicol 39, 103-25. Yu, H., N. M. Luscombe, et al. (2004). Annotation transfer between genomes: protein-protein interologs and protein-DNA regulogs. Genome Res 14, 1107-18. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/40672 | - |
| dc.description.abstract | 神經母細胞瘤是源自交感神經系統的異構腫瘤，有著多變的臨床與生物行為，是兒童常見癌症之一。為了研究神經母細胞瘤複雜的調節機制，許多預後生物因子被找到，特別是 v-myc myelocytomatosis viral related oncogene (MYCN) 。帶有多倍數 MYCN 的病人預後則非常差。然而，MYCN 表現後導致癌症發生的機轉仍然十分不清楚。
微陣列晶片技術是強而有力並且高通量的方法，用以精確的了解整體性的基因表現變化。在我們的研究中，我們總共進行了 20 片台灣神經母細胞瘤病人的微陣列晶片實驗。除此之外，我們使用生物路徑比對以及電腦模擬預測，來建構蛋白質交互作用網路。 我們用三倍變化為篩選標準，展示了有 2718 個基因有差異性的表現。經過非主觀的階層式分群法，我們發現 MYCN 增幅的微陣列晶片樣本會與 MYCN未增幅的分別開來。藉由生物路徑比對，aryl hydrocarbon receptor (AHR) 路徑是顯著表現的路徑之一，而 MYCN 與 AHR 的基因表現有著高度的相關性，除此之外，我們建構了蛋白質交互作用網路， MYCN 在網路中會透過兩個節點而連結到 AHR ，而預測結果與 MYCN 直接連結的基因還有與 AHR 直接連結的兩組基因表現檔案，都顯示了高度相關。 我們的發現指出了 MYCN 和 AHR 有著高度相關，而且 AHR 也可能在神經母細胞瘤發展中扮演重要的角色。 AHR 與 MYCN 參與的交互作用網路對於了解 MYCN 表現的調節機制會有相當大的幫助。此研究將有可能為神經母細胞瘤的治療帶來一道曙光。 | zh_TW |
| dc.description.abstract | Neuroblastoma, a heterogeneous tumor with variable clinical and biological behavior, is one of the most common pediatric cancers that derived from sympathetic nervous system. To explore the heterogeneous behavior of neuroblastoma, many prognostic biological markers have been discovered, especially v-myc myelocytomatosis viral related oncogene (MYCN) amplification predict a poor prognosis. However, the regulatory mechanism by MYCN expression still has been unclear.
The microarray technique is a powerful and high-throughput method for accurately determining changes in global gene expressions. In this study, we performed microarray experiment to measure gene expression profiles of 20 Taiwanese neuroblastoma patients. Furthermore, we used pathway mapping and in silico interaction prediction to elucidate and construct the protein interaction network. We showed that 2718 genes are differentially expressed between neuroblastoma and control samples using 3-fold change as cut-off. By using unsupervised hierarchical clustering, we found that MYCN-amplified samples separated from not-amplified samples. By pathway mapping, the aryl hydrocarbon receptor (AHR) pathway was significant and MYCN and AHR have highly correlation in the expression profile. In addition, we constructed the protein network which MCYN connect through 2 nodes with AHR network and the gene expressions of MYCN- and AHR- interacted proteins are highly relevant. Our findings indicate that MYCN and AHR have highly correlation and AHR may also play an important role in neuroblastoma development. The protein-protein interaction network of AHR and MYCN involved in neuroblastoma is useful to know the regulatory mechanism by MYCN expression. This study shed light on neuroblastoma therapy. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-14T16:55:25Z (GMT). No. of bitstreams: 1 ntu-97-R95b43018-1.pdf: 3393078 bytes, checksum: 9a9dda6c887b047d83f341c4cb0ec0f7 (MD5) Previous issue date: 2008 | en |
| dc.description.tableofcontents | 口試委員審定書 I
謝 辭 II 摘 要 IV Abstract V 第一章 前言 1 1.1神經母細胞瘤 (neuroblastoma) 簡介 1 1.2 AHR路徑 4 1.3 MYCN 6 1.4 E2F1 7 1.5微陣列晶片 (Microarray) 7 1.6 蛋白質交互作用 (Protein-protein interaction) 10 1.7生物路徑比對 (Pathway mapping) 11 1.8 Cytoscape 12 1.9階層式分群法(Hierarchical Clustering) 13 第二章 實驗材料與方法 14 2.1實驗流程 14 2.2 微陣列晶片 (Microarray) 15 2.3 微陣列晶片資料分析 (GeneSpring GX) 16 2.4 Ingenuity Pathway Analysis (IPA) 17 2.5 Protein-Protein Interaction (PPI) 預測 18 2.6 反轉錄 (Reverse Transcription)製備cDNA 19 2.7螢光原位雜合 (fluorescence in situ hybridization, FISH) 21 2.8 即時定量聚合酶鏈鎖反應引子設計 (Real-Time PCR Primer Design) 22 2.9即時定量聚合酶鏈鎖反應(Real-Time PCR) 23 第三章 結果 26 3.1非主觀的階層式分群法 26 3.2 生物路徑比對 27 3.3 蛋白質交互作用網路預測 31 3.4 以微陣列晶片數據比對預測蛋白質交互作用網路 35 3.5 以即時定量聚合酶連鎖反應定量特定基因表現 37 第四章 討 論 43 第五章 結 論 48 參考文獻 50 發表文章 54 附錄 58 | |
| dc.language.iso | zh-TW | |
| dc.subject | 蛋白質交互作用網路 | zh_TW |
| dc.subject | 神經母細胞瘤 | zh_TW |
| dc.subject | AHR | zh_TW |
| dc.subject | MYCN | zh_TW |
| dc.subject | 微陣列晶片 | zh_TW |
| dc.subject | neuroblastoma | en |
| dc.subject | protein-protein interaction network | en |
| dc.subject | microarray | en |
| dc.subject | MYCN | en |
| dc.subject | AHR | en |
| dc.title | 神經母細胞瘤中與AHR和MYCN相關之蛋白質交互作用網路的研究 | zh_TW |
| dc.title | Protein-protein Interaction Network of AHR and MYCN Involved in Neuroblastoma | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 96-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 黃 宣誠,許文明 | |
| dc.subject.keyword | 神經母細胞瘤,AHR,MYCN,微陣列晶片,蛋白質交互作用網路, | zh_TW |
| dc.subject.keyword | neuroblastoma,AHR,MYCN,microarray,protein-protein interaction network, | en |
| dc.relation.page | 52 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2008-07-30 | |
| dc.contributor.author-college | 生命科學院 | zh_TW |
| dc.contributor.author-dept | 分子與細胞生物學研究所 | zh_TW |
| 顯示於系所單位： | 分子與細胞生物學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-97-1.pdf 未授權公開取用 | 3.31 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。